Trial · NCT07891832
Video Laryngeal Mask SaCoVLM Versus LMA Supreme and Ambu AuraGain in Children
NCT07891832, Not applicable, Not yet recruiting, Masarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s.
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Video Laryngeal Mask SaCoVLM Versus LMA Supreme and Ambu AuraGain in Children. Trials, record NCT07891832. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07891832
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Video Laryngeal Mask SaCoVLM Versus LMA Supreme and Ambu AuraGain in Children
- NCT number
- NCT07891832
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 135 participants, estimated
- Lead sponsor
- Masarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s.
- Conditions
- Airway Management, Anesthesia, General, Pediatric Anesthesia
- Interventions
- SaCoVLM video laryngeal mask, LMA Supreme, Ambu AuraGain
- First posted
- 2026-10-23
- Last updated
- 2026-10-23
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Oropharyngeal leak pressure (OLP) | From device insertion up to 5 minutes after insertion | Airway pressure (cmH2O) at which the circuit manometer reading becomes stable, measured with the breathing circuit in manual mode, ventilation paused, fresh gas flow 10 L/min and the APL valve set to 50 cmH2O, after stable ventilation is achieved. |
| Secondary | First-attempt insertion success rate | From the start of the first insertion attempt until successful insertion (maximum 3 attempts), up to 10 minutes | Proportion of patients in whom the device is successfully inserted with adequate ventilation at the first attempt. |
| Secondary | Need for device repositioning or reinsertion during surgery | From device insertion until device removal at the end of anaesthesia, up to 5 hours | Proportion of patients requiring repositioning, reinsertion of the device or other airway intervention after successful insertion. |
| Secondary | Incidence of perioperative airway-related complications | From device insertion until device removal at the end of anaesthesia, up to 5 hours | Proportion of patients with at least one of: desaturation (SpO2 \< 92%), laryngospasm, bronchospasm, aspiration; each complication also reported separately. |
| Secondary | Blood staining of the device on removal | At device removal at the end of emergence from anaesthesia, up to 5 hours after insertion | Proportion of patients with visible blood on the device or in secretions after device removal. |
| Secondary | Video image quality (SaCoVLM group only) | Immediately after OLP measurement, up to 5 minutes after device insertion | Quality of the video image of the integrated display rated by the inserting anaesthesiologist on a 5-point Likert scale (1 = worst, 5 = best; image quality only). |
| Secondary | Percentage of glottic opening (POGO) (SaCoVLM group only) | Immediately after OLP measurement, up to 5 minutes after device insertion | Percentage of the glottic opening visible on the integrated video display (0-100%). |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers3
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07891832
GET https://conductscience.org/api/trials/v1/NCT07891832/registered